Several hedge funds and institutional investors have recently changed their investments in Baxter International (BAX). First PREMIER Bank invested $25,000 in BAX in Q3. Innealta Capital LLC bought $27,000 worth of BAX shares in Q2, while LRI Investments LLC acquired $39,000 worth in Q1. Versant Capital Management Inc increased their stake in BAX by 974.2% in Q2, now holding 1,332 shares valued at $45,000. Trust Co. of Vermont raised their holdings by 31.0% in Q4, owning 1,870 shares worth $72,000. Currently, 90.19% of the stock is owned by hedge funds and institutions.
Wall Street Analyst Opinions
Analysts have mixed reviews on BAX. Goldman Sachs raised its price target from $36.00 to $40.00, maintaining a “neutral” rating. Morgan Stanley downgraded its rating from “equal weight” to “underweight,” lowering the target from $39.00 to $30.00. StockNews.com downgraded BAX from “buy” to “hold,” while JPMorgan Chase cut its target from $44.00 to $42.00, keeping a “neutral” stance. Citigroup increased its target from $38.00 to $40.00. Overall, BAX has one sell rating, nine holds, and two buys, with an average target price of $42.00.
Baxter International Stock Overview
BAX opened at $36.65. The stock has a 52-week low of $31.01 and a high of $44.01. Baxter’s market cap is $18.68 billion, with a P/E ratio of 7.05. It recently reported $0.68 earnings per share (EPS), beating estimates of $0.66. The previous year’s EPS was $0.55, showing a revenue increase of 2.8% year-over-year. Analysts expect BAX to post earnings of $2.96 this fiscal year.
Baxter International Company Profile
Baxter International Inc. provides a range of healthcare products globally. It operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. Their offerings include IV solutions, infusion devices, specialty pharmaceuticals, and advanced surgical equipment.
Related Articles
- Five stocks we like better than Baxter International
- What is the NASDAQ Stock Exchange?
- Goldman Sachs Earnings Reveal Key Market Insights
- Best Large-Cap Stocks to Buy
- AMD’s AI Momentum: Can It Impress?
- Calculating Options Profits
- 2 Lithium Stocks That Could Be Targets
Want to see other hedge funds holding BAX? Visit HoldingsChannel.com for the latest filings and trades for Baxter International Inc. (NYSE:BAX).
Get Daily Updates on Baxter International – Enter your email below for news and analyst ratings from MarketBeat.com’s FREE daily newsletter.
`
